Antiplatelet antibodies during the course of HIV-preventive vaccine trial.
Kaplan
C
C
Morel-Kopp
M C
MC
Kieny
M P
MP
Kolbe
H
H
Salmon
P
P
Sicard
D
D
Pialoux
G
G
Meignier
B
B
Excler
J L
JL
Plotkin
S
S
D016915:AIDS Vaccines / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D003429:Cross Reactions; D015686:Gene Products, env / Q000276:immunology; D015483:HIV Antibodies / Q000276:immunology*; D019302:HIV Envelope Protein gp160; D015658:HIV Infections / Q000517:prevention & control*; D015497:HIV-1 / Q000276:immunology*; D006801:Humans; D019038:Platelet Glycoprotein GPIb-IX Complex / Q000276:immunology*; D011498:Protein Precursors / Q000276:immunology
D016915:AIDS Vaccines; D001323:Autoantibodies; D015686:Gene Products, env; D015483:HIV Antibodies; D019302:HIV Envelope Protein gp160; D019038:Platelet Glycoprotein GPIb-IX Complex; D011498:Protein Precursors